HD Clinical Ltd. has been acquired by NEXUS AG
NEXUS AG has acquired HD Clinical Ltd. Through this acquisition, NEXUS has gained a recognized and internationally active team of experts in structured diagnostic reporting and image processing. This will provide new regional access, strengthening its strong European market position in software, particularly for internal medicine.
HD Clinical was founded in 2005 by a group of clinicians to build an electronic clinical record system starting from departmental requirements and delivering management data derived from real-world patient information. This was a departure from the historic top-down approach of electronic patient record (EPR) systems, which were essentially upgraded patient administration systems with ‘one-size-fits-all’ clinical functionality bolted on. For 17 years, HD Clinical has been delivering digital clinical solutions to healthcare organizations around the world. The company’s solutions are used by 146 organizations across the globe, joining up healthcare organizations and hospital departments to improve the patient experience. The HD Clinical approach is designed to capture maximum engagement from clinical teams by meeting their needs and recognizing the specific requirements of each specialty. Their software and hardware are designed by their in-house team in the HD Clinical UK office.
Nexus AG provides innovative software solutions that allow users at healthcare facilities to focus on what really matters. Their goal is to offer all departments in hospitals, psychiatric wards and rehabilitation and residential institutions the best solution to the challenges they face every day.
Oaklins Evelyn Partners, one of Oaklins’ member firms in the UK, acted as lead the advisor to HD Clinical’s shareholders on the sale of the business. After winning a competitive pitch process, the team advised on all aspects of the transaction, from initial buyer research and preparation for sale to the preparation of marketing documents, leading negotiations and buyer meetings, managing due diligence and general project management throughout the deal.
Dr Clive Layton
Founder, HD Clinical
Sprechen Sie mit dem Deal Team
Prashant Dhokia
Oaklins Evelyn Partners
Transaktionen
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Mehr erfahrenGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Mehr erfahrenAmber-Allen Publishing has sold its publishing assets to Penguin Publishing Group
Amber-Allen Publishing, home to some of the world’s most influential personal development books, most notably “The Four Agreements” by Don Miguel Ruiz and Janet Mills, has sold its publishing assets to Penguin Publishing Group. When the acquisition is complete, the Amber-Allen list will be managed by the TarcherPerigee imprint.
Mehr erfahren